Inequalities in Dementia: Unveiling the Evidence and Forging a Path Towards Greater Understanding
![Inequalities in Dementia: Unveiling the Evidence and Forging a Path to Greater Understanding](https://www.ohe.org/wp-content/uploads/2024/06/Inequalities-in-Dementia.jpeg)
Biosimilars have similar, but not identical, structures to branded biologic drugs. Being comparable, but not interchangeable, they can differ in cost-effectiveness and accessibility. Increased competition, however, can reduce healthcare system costs.